GlassScriptPhysician profile
Tamie Babb
NPI 1336172410
$1,685.91
in general payments reported to CMS, 2019-2025
24 companies · $28.39 in 2025
The $28.39 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $249 · 2021: $539 · 2022: $322 · 2023: $204 · 2025: $28.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $404.48 | 2019-2023 | Liletta |
| Aspira Women'S Health INC | $220.28 | 2021-2023 | Ova1 |
| Daiichi Sankyo INC. | $220.20 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.00 | 2020-2022 | |
| Coopersurgical, INC. | $88.47 | 2019-2025 | Endosee |
| Merck Sharp & Dohme LLC | $77.16 | 2019-2023 | Gardasil 9 |
| Organon LLC | $76.97 | 2021-2023 | Nexplanon |
| Exeltis, USA INC. | $76.31 | 2020-2022 | |
| Agile Therapeutics, INC. | $56.22 | 2021-2022 | |
| Hologic Sales and Service, LLC | $56.10 | 2019-2023 | Aptima |
| Exact Sciences Corporation | $39.83 | 2023 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $37.86 | 2019-2021 | |
| Evofem Biosciences, INC. | $36.96 | 2021-2022 | |
| Duchesnay USA Incorporated | $25.97 | 2019 | |
| Allergan, INC. | $25.77 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $23.53 | 2019-2020 | |
| Pfizer INC. | $20.48 | 2023 | |
| Mayne Pharma Commercial LLC | $20.00 | 2022 | |
| Therapeuticsmd, INC. | $17.77 | 2022 | |
| Ascend Therapeutics US, LLC | $17.60 | 2020 | |
| Astellas Pharma US INC | $15.13 | 2023 | Veozah |
| Avion Pharmaceuticals | $14.22 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.43 | 2019 | |
| Myovant Sciences INC. | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamie Babb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.